Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.

Blank, PR, Filipits, M, Dubsky, P, Gutzwiller, F, Lux, MP, Brase, JC, Weber, KE, Rudas, M, Greil, R, Loibl, S, Szucs, TD, Kronenwett, R, Schwenkglenks, M, Gnant, M.

http://www.ncbi.nlm.nih.gov/pubmed/25404424